INSP Investors Invited to Join Fraud Investigation into Inspire Medical Systems

The firm The Schall Law Firm announced an investigation on behalf of shareholders of Inspire Medical Systems, Inc. (“Inspire” or the “Company”, NYSE: INSP) into potential violations of securities laws. The probe focuses on whether Inspire issued false or misleading statements — or failed to disclose material information — in connection with its August 4, 2025 earnings release, when it lowered full‑year revenue guidance and revealed that rollout of its “Inspire V” system was delayed because treatment centers could not bill Medicare until July 1. Following the disclosure, Inspire’s stock dropped about 40.6% on August 5. If you are a shareholder who suffered a loss, please contact the firm for a free consultation. #InspireInvestigation #ShareholderRights #SecuritiesFraud #InspireMedicalSystems #SlimScan #GrowthStocks #CANSLIM